trending Market Intelligence /marketintelligence/en/news-insights/trending/iSnAr740yWuNW46TycDF4g2 content esgSubNav
In This List

2 FluoroPharma directors resign

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


2 FluoroPharma directors resign

Peter Conti and Johan Spoor agreed to resign as directors of FluoroPharma Medical Inc., effective Jan. 1, 2017.

The resignations are not due to any disagreements on any matter relating to the company's operations, policies and practices.